Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
DORZOTRUS, DORZOSOPT, TRUSOLAMIDE, DORZOLAMIDE NHPL, TRUSOPTIDE, TORZOLAMIDE, DORZOLAMIDE NEOHEALTH (Neo Health (Australia) Pty Ltd)
Product name
DORZOTRUS, DORZOSOPT, TRUSOLAMIDE, DORZOLAMIDE NHPL, TRUSOPTIDE, TORZOLAMIDE, DORZOLAMIDE NEOHEALTH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
131 working days (255)
Active ingredients
Dorzolamide hydrochloride
Registration type
New generic medicine
Indication
DORZOTRUS, DORZOSOPT, TRUSOLAMIDE, DORZOLAMIDE NHPL, TRUSOPTIDE, TORZOLAMIDE, DORZOLAMIDE NEOHEALTH (eye drops) is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma